Icosavax, Inc. Common Stock
ICVX
ICVX was delisted on the 16th of February, 2024.
64 hedge funds and large institutions have $331M invested in Icosavax, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 6 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 14
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
3% more funds holding
Funds holding: 62 → 64 (+2)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
22% less capital invested
Capital invested by funds: $423M → $331M (-$92.2M)
28% less call options, than puts
Call options by funds: $128K | Put options by funds: $178K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.73M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$4.98M |
| 3 |
BlackRock
New York
|
+$1.74M |
| 4 |
Barclays
London,
United Kingdom
|
+$1.63M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4.83M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$876K |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$825K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$370K |
ICVX Hedge Fund Activity: Q3 2023 in Review
64 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q3 2023, worth a combined $331M — down 22% from $423M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ICVX positions and 6 closed out — a net gain of 2 holders — while 19 added to existing stakes and 14 trimmed.
The largest buyer was Vanguard Group, adding an estimated $7.73M. The largest seller was Fidelity Investments, cutting an estimated $10.4M.
- 64 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q3 2023, up from 62 in Q2 2023.
- Funds reported $331M of Icosavax, Inc. Common Stock stock for Q3 2023, down 22% quarter-over-quarter.
- 8 funds opened new Icosavax, Inc. Common Stock positions in Q3 2023 and 6 closed out, a net change of +2 holders.
- The largest Icosavax, Inc. Common Stock buyer in Q3 2023 was Vanguard Group, an estimated $7.73M added.
- The largest Icosavax, Inc. Common Stock seller in Q3 2023 was Fidelity Investments, an estimated $10.4M sold.
Based on aggregated 13F filings for Q3 2023.